B7-H6 Promotes Cell Proliferation, Migration and Invasion of Non-Hodgkin Lymphoma via Ras/MEK/ERK Pathway Based on Quantitative Phosphoproteomics Data
B7-H6 Promotes Cell Proliferation, Migration and Invasion of Non-Hodgkin Lymphoma via Ras/MEK/ERK Pathway Based on Quantitative Phosphoproteomics Data
复制标题
基于定量磷酸化蛋白质组学数据 B7-H6 通过 Ras/MEK/ERK 通路促进非霍奇金淋巴瘤细胞增殖、迁移和侵袭
DOI:
10.2147/ott.s257512
复制
发表时间:
2020-06
影响因子:
4
通讯作者:
Xiaoyan Ke
中科院分区:
文献类型:
--
作者:
Siyuan Yang;Lei Yuan;Yanfang Wang;Mingxia Zhu;Jing Wang;Xiaoyan Ke
Purpose B7 homologue 6 (B7-H6) has been found at an up-regulated level in multiple cancer cells and identified to be positively correlated with inferior clinical features. In non-Hodgkin lymphoma (NHL), however, the roles of B7-H6 and the underlying mechanism of action remain unclear. Through in vivo and in vitro experiments, the aim of this study was to explore the regulatory mechanism of B7-H6 in NHL in order to provide new therapeutic strategies that can potentially be applied in clinical practice. Methods The expression of B7-H6 in T-lymphoblastic lymphoma (TLBL), diffuse large B cell lymphoma (DLBCL) and lymph node reactive hyperplasia (LRH) tissues were compared by immunohistochemistry. A total of 10 NHL cell lines were screened by Western blot to evaluate the expression of B7-H6. The effects of B7-H6 knockdown on cell proliferation, migration and invasion of NHL cells were studied in vivo using a transplanted tumor mice model, and in vitro by Cell Counting Kit-8 (CCK-8) and Transwell assays. Quantitative phosphoproteomics was performed to identify the changes of protein phosphorylation and related pathways affected by B7-H6. The effects of B7-H6 on NHL were validated via B7-H6 overexpression and pathway inhibitor assays. Results The expression levels of B7-H6 in NHL cell lines, and TLBL and DLBCL tissues were significantly increased compared with those in the control groups. Inhibition of cell proliferation, migration and invasion was observed in Jurkat and Raji cells with B7-H6 knockdown. The ability of B7-H6 in promoting tumorigenesis was further validated by in vivo experiments. In addition, Ras and HIF-1 signaling pathways were shown to be significantly affected by B7-H6 through quantitative phosphorylation proteomics analysis. Ras/MEK/ERK pathway was verified to be significantly inhibited after B7-H6 knockdown by Western blot analysis. Strikingly, MEK inhibitor AZD8330 was found to have the ability to sufficiently inhibit Ras/MEK/ERK pathway, partially reverse cell proliferation and completely reverse cell migration and invasion induced by B7-H6. Conclusion B7-H6 promotes cell proliferation, migration and invasion in NHL via Ras/MEK/ERK pathway. Hence, B7-H6 or Ras/MEK/ERK pathway targeting may be used as potential therapeutics for treating NHL.
登录
查看更多内容
影响因子:
--
作者:
Eblen ST
通讯作者:
Eblen ST
DOI:
10.1007/978-3-642-02202-9_346
发表时间:
2012
期刊:
--
影响因子:
--
作者:
H. S. Nicholson
通讯作者:
H. S. Nicholson
影响因子:
6.4
作者:
Specht, Elisa;Kaemmerer, Daniel;Lupp, Amelie
通讯作者:
Lupp, Amelie
影响因子:
4
作者:
SCHLESSINGER, J
通讯作者:
SCHLESSINGER, J
影响因子:
4.3
作者:
Matsuki E;Younes A
通讯作者:
Younes A